|Sialorrhea usually is caused by neuromuscular dysfunction, hypersecretion, sensory dysfunction, or anatomic motor dysfunction||, is associate director of otolaryngology at the Children's Hospital of Philadelphia and professor in the Department of Otolaryngology—Head and Neck Surgery at the University of Pennsylvania School of Medicine|
|Glycopyrrolate treatment of chronic drooling||04 mg per kg per dose orally, two to three times daily; titrate to effectiveness and tolerability Scopolamine Transderm Scop Patch, 1|
Under normal circumstances, persons are able to compensate for increased salivation by swallowing.26
|Treatment of sialorrhea with glycopyrrolate: a double-blind, dose-ranging study||The injection of botulinum toxin type A into the parotid and submandibular glands is safe and effective in controlling drooling, but the effects fade in several months, and repeat injections are necessary|
|J Behav Ther Exp Psychiatry||This content is owned by the AAFP|
Reprints are not available from the authors.
|If sialorrhea continues to interfere with the patient's health and quality of life after non-invasive measures have been tried, medication, radiation, and surgical therapy should be considered||66 per 1-mg tablet Children: 0|
|This condition is normal in infants but usually stops by 15 to 18 months of age||Orofacial regulation therapy in children with Down syndrome, using the methods and appliances of Castillo-Morales|
, mercury vapor , and rabies.